Overview
- The WHO released its Global TB Report 2025 on November 12, detailing India’s 2024 tally of about 27.1 lakh cases and over three lakh deaths.
- India’s TB incidence fell 21% since 2015 to 187 per 100,000 people, outpacing the global decline of 12% over the same period.
- Treatment coverage rose to 92% in 2024 from 85% in 2023, and the treatment‑success rate for those who began therapy in 2023 reached 90%.
- India still accounts for nearly one‑third of global drug‑resistant TB, even as shorter BPaL/BPaLM regimens and newer drugs expand, with India the sole supplier of pretomanid.
- Program upgrades include wider molecular testing, AI‑enabled X‑ray screening and the Ni‑kshay digital platform, with experts calling for sharply increased funding to sustain gains.